EMA Authorised: Irbesartan Teva (irbesartan) — Teva B.V.

View source ↗

Summary

The European Medicines Agency authorised a generic irbesartan product by Teva B.V. for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Irbesartan Teva (irbesartan)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Teva B.V.. Decision date: 28/01/2025